Medigene eyeing more immunotherapy deals after Bluebird pact

FRANKFURT, Dec 19 (Reuters) - German biotech firm Medigene

said it is drawing more interest from prospective

alliance partners for its technology to boost the immune

response to cancer after its...

Read more